社会支持干预对医疗患者生存的影响:非随机临床试验的元分析
Ksenia Illinykh-Bair1, Timothy B Smith1
1Department of Counseling Psychology and Special Education, Brigham Young University, Provo, UT 84602, USA.
Healthcare (Basel, Switzerland)
|January 28, 2026
概括
对于患有慢性疾病的患者来说,社会支持干预措施显示出潜在的生存益处,但这些影响可能只会在长期随访研究中变得明显. 需要更多的研究来证实这些发现.
科学领域:
- 医学研究 医学研究
- 公共卫生 公共卫生
- 社会科学 社会科学 社会科学
背景情况:
- 众所周知,社会支持可以提高治疗慢性疾病的医疗患者的性.
- 社会支持的影响超越了情感福祉,影响了身体健康结果.
- 为慢性病患者确定有效的社会支持干预措施是医疗保健的优先事项.
研究的目的:
- 评估慢性病患者医疗社会支持干预措施的生存益处.
- 综合现有关于社会支持和患者存活率的非随机试验的证据.
主要方法:
- 对14项涉及39493名医疗患者的非随机试验的元分析.
- 总结了先前对社会支持干预措施和生存益处的审查数据.
- 分析包括危险比率和赔率比率数据,以及异质性评估 (I2,Q-统计).
主要成果:
- 危险比率数据 (4项研究) 没有达到统计学意义 (HR = 2.10,p = 0.0546).
- 几率比率数据 (10项研究) 显示较小,无意义的影响 (OR = 1.27,p > 0.05).
- 在危险比率 (I2 = 89%) 和几率比率 (I2 = 53%) 数据中观察到显著的异质性.
- 用较长时间收集数据的研究表明,接受社会支持的患者的生存率有所改善.
结论:
- 社会支持干预措施的生存益处可能需要长时间的观察期才能显现.
- 用更大的数据集进行进一步研究和长期跟进对于得出最终结论至关重要.
- 这些发现强调了持续的社会支持在慢性疾病管理中的潜在,但尚未证实的作用.
更多相关视频
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.6K
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.8K
相关概念视频
Clinical Trials
10.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.4K
Clinical Trials: Overview
4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Statistical Software for Data Analysis and Clinical Trials
1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Introduction To Survival Analysis
771
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
771
Comparing the Survival Analysis of Two or More Groups
583
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
583
Truncation in Survival Analysis
612
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
612
